Efficacy and Safety of Switching from Prostaglandin Analog Therapy to Prostaglandin / Timolol Fixed Combination or Prostaglandin / Brimonidine Therapy.

CONCLUSION: Switching from a PG analogue to PG/timolol FCs or to PG with brimonidine was equally safe (systemically and topically) and effective in reducing IOP. Thus, PG with brimonidine might be appropriate medication in patients who cannot use PG/timolol FCs due to repiratory or circulatory disease. PMID: 28761569 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/28761569?dopt=Abstract

Source: Open Ophthalmology Journal - August 2, 2017 Category: Opthalmology Tags: Open Ophthalmol J Source Type: research